Oral semaglutide cuts major heart risks in people with type 2 diabetes by 14%, offering a powerful pill-based option. Both ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Researchers warned that to achieve such reductions, greater uptake of the medication among indicated patients is needed.

Savvy pharma-stock investors know that an oral GLP-1 drug from Novo Nordisk called Rybelsus has been on the market as a ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic neuropathy.

Others are more direct, recommending peptides for weight loss and describing their experiences using them. These include the usual suspects, like semaglutide and tirzepatide, but also retatrutide ...

This examined the use of oral semaglutide, a glucagon-like peptide-1 receptor agonist ... formulate with absorption enhancer sodium-N-(8-(2-hydroxybenzoyl) amino caprylate (SNAC) or 14mg placebo ...

Many other synthetic peptides — made in a lab — are approved as drugs, including semaglutide (the active ingredient in Ozempic) and linaclotide (the active ingredient in Linzess, a drug for ...

For patients with diabetes, semaglutide use is associated with an increased risk for nonarteritic anterior ischemic optic ...